RANI - Rani Therapeutics Holdings Inc - Ordinary Shares Class A
IEX Last Trade
3.26
0.440 13.497%
Share volume: 367,613
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$2.82
0.44
15.60%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
4.23%
1 Month
13.07%
3 Months
-37.50%
6 Months
-6.71%
1 Year
-16.88%
2 Year
-63.92%
Key data
Stock price
$3.26
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.82 - $8.75
52 WEEK CHANGE
-$0.16
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Talat Imran
Region: US
Website: https://www.ranitherapeutics.com
Employees: 114
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.ranitherapeutics.com
Employees: 114
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.
Recent news